Rémy Cointreau SA (OTCMKTS:REMYY - Get Free Report) saw a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 7,500 shares, a decrease of 35.9% from the February 13th total of 11,700 shares. Based on an average daily volume of 407,500 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company's stock are short sold.
Rémy Cointreau Stock Down 2.6 %
Rémy Cointreau stock traded down $0.13 during trading hours on Wednesday, hitting $4.87. The stock had a trading volume of 24,226 shares, compared to its average volume of 86,224. The stock's 50-day moving average price is $5.36 and its 200-day moving average price is $6.08. Rémy Cointreau has a 12-month low of $4.75 and a 12-month high of $10.38.
About Rémy Cointreau
(
Get Free Report)
Rémy Cointreau SA, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. It operates through Rémy Martin, Liqueurs & Spirits, and Partner Brands segments. The company offers cognacs, liqueurs, single malt whiskies, gins, rums, brandies, wines, and champagnes primarily under the Cointreau, Metaxa, St-Rémy, Mount Gay, Bruichladdich, The Botanist, Westland, Le Domaine des Hautes Glaces, Belle de Brillet, Telmont, Port Charlotte, Octomore, Rémy Martin, and LOUIS XIII brands.
Featured Articles
Before you consider Rémy Cointreau, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rémy Cointreau wasn't on the list.
While Rémy Cointreau currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.